VFA
CRL icon

Valeo Financial Advisors’s Charles River Laboratories CRL Stock Holding History

Valeo Financial Advisors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-120
Closed -$35K – 784
2021
Q1 		$35K Buy
+120
New +$33.4K ﹤0.01% 993
2020
Q3 		– Sell
-121
Closed -$21K – 1703
2020
Q2 		$21K Buy
121
+50
+70% +$7.98K ﹤0.01% 1039
2020
Q1 		$10K Sell
71
-170
-71% -$25.5K ﹤0.01% 1084
2019
Q4 		$37K Buy
241
+170
+239% +$23.5K ﹤0.01% 751
2019
Q3 		$9K Sell
71
-1
-1% -$134 ﹤0.01% 1046
2019
Q2 		$10K Hold
72
– – ﹤0.01% 1018
2019
Q1 		$10K Hold
72
– – ﹤0.01% 959
2018
Q4 		$8K Sell
72
-42
-37% -$5.26K ﹤0.01% 935
2018
Q3 		$14K Sell
114
-2
-2% -$247 ﹤0.01% 866
2018
Q2 		$14K Sell
116
-21
-15% -$2.27K ﹤0.01% 860
2018
Q1 		$15K Buy
137
+65
+90% +$7.01K ﹤0.01% 809
2017
Q4 		$8K Sell
72
-2
-3% -$218 ﹤0.01% 872
2017
Q3 		$8K Buy
+74
New +$7.6K ﹤0.01% 750

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Valeo Financial Advisors's CRL Position: Q2 2021 in Review

Valeo Financial Advisors sold out of Charles River Laboratories (CRL) in Q2 2021, closing a stake of 120 shares — an estimated $35K sold.

Valeo Financial Advisors first reported a position in CRL in Q3 2017 and held it in 13 quarters. The position peaked at $37K in Q4 2019. 639 funds tracked by Wall St. Rank hold CRL as of Q2 2021.

  • Valeo Financial Advisors reported no remaining Charles River Laboratories position as of Q2 2021 after selling out during the quarter.
  • Valeo Financial Advisors sold 120 Charles River Laboratories shares in Q2 2021, an estimated $35K.
  • Valeo Financial Advisors first reported a position in Charles River Laboratories in Q3 2017 and held it in 13 quarters.
  • Valeo Financial Advisors's Charles River Laboratories position peaked at $37K in Q4 2019.
  • 639 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.